Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study is aimed at assessing the tolerability and pharmacokinetic parameters of the
fexinidazole in healthy volunteers. In animal models of both acute and chronic experimental
Trypanosomiasis infections, fexinidazole shows highly promising efficacy.